Founders Capital Management (Texas)’s Medtronic MDT Stock Holding History

Founders Capital Management (Texas)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$2.4K	–	413
2025 Q4	$2.4K	Hold	25	–	–	﹤0.01%	364
2025 Q3	$2.38K	Hold	25	–	–	﹤0.01%	346
2025 Q2	$2.18K	Hold	25	–	–	﹤0.01%	339
2025 Q1	$2.25K	Buy	+25	New	+$2.24K	﹤0.01%	324
2023 Q3	–	Sell	-291	Closed	-$25.6K	–	416
2023 Q2	$25.6K	Hold	291	–	–	0.02%	208
2023 Q1	$23K	Hold	291	–	–	0.02%	216
2022 Q4	$23K	Hold	291	–	–	0.02%	209
2022 Q3	$23K	Hold	291	–	–	0.02%	201
2022 Q2	$26K	Buy	291 +66	+29%	+$6.69K	0.02%	197
2022 Q1	$23K	Hold	225	–	–	0.01%	195
2021 Q4	$23K	Hold	225	–	–	0.01%	195
2021 Q3	$28K	Hold	225	–	–	0.02%	176
2021 Q2	$28K	Hold	225	–	–	0.02%	169
2021 Q1	$27K	Sell	225 -225	-50%	-$26.4K	0.02%	164
2020 Q4	$48K	Buy	+450	New	+$49.5K	0.03%	107
2020 Q1	$42K	Buy	450 +225	+100%	+$23.9K	0.04%	98
2019 Q4	$26K	Hold	225	–	–	0.02%	155
2019 Q3	$24K	Hold	225	–	–	0.02%	164
2019 Q2	$22K	Hold	225	–	–	0.02%	176
2019 Q1	$20K	Hold	225	–	–	0.02%	178
2018 Q4	$20K	Hold	225	–	–	0.02%	172
2018 Q3	$22K	Hold	225	–	–	0.02%	170
2018 Q2	$19K	Sell	225 -1,915	-89%	-$160K	0.02%	193
2018 Q1	$172K	Hold	2,140	–	–	0.14%	82
2017 Q4	$173K	Hold	2,140	–	–	0.14%	84
2017 Q3	$166K	Buy	2,140 +400	+23%	+$33.2K	0.14%	86
2017 Q2	$154K	Sell	1,740 -850	-33%	-$71.7K	0.14%	83
2017 Q1	$209K	Buy	+2,590	New	+$202K	0.19%	76

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Founders Capital Management (Texas)'s MDT Position: Q1 2026 in Review

Founders Capital Management (Texas) sold out of Medtronic (MDT) in Q1 2026, closing a stake of 25 shares — an estimated $2.4K sold.

Founders Capital Management (Texas) first reported a position in MDT in Q1 2017 and held it in 28 quarters. The position peaked at $209K in Q1 2017. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Founders Capital Management (Texas) reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Founders Capital Management (Texas) sold 25 Medtronic shares in Q1 2026, an estimated $2.4K.
Founders Capital Management (Texas) first reported a position in Medtronic in Q1 2017 and held it in 28 quarters.
Founders Capital Management (Texas)'s Medtronic position peaked at $209K in Q1 2017.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2026, filed 21 Apr 2026.